How much funding has PANLUMINATE INC raised?

PANLUMINATE INC has raised $3.6M in total funding, most recently a Grant round.

Who are PANLUMINATE INC's investors?

PANLUMINATE INC's investors include National Institutes of Health.

When was PANLUMINATE INC founded?

PANLUMINATE INC was founded in 2022.

Where is PANLUMINATE INC headquartered?

PANLUMINATE INC is headquartered in New Haven, Connecticut, United States.

What industry is PANLUMINATE INC in?

PANLUMINATE INC operates in Biotech, Healthcare, Life Sciences.

How many employees does PANLUMINATE INC have?

PANLUMINATE INC has 1-10 employees.

PANLUMINATE INC

Molecular labeling and connectomics

New Haven, United States · Founded 2022 · $3.6M raised

Biotech

Healthcare

Life Sciences

Headquarters: New Haven, Connecticut
Employees: 1–10
Founded: 2022
Business Model: B2B

Website: panluminate.com
Total Funding: $3.6M
Last Round: $1.4M GrantJan 2025
Rounds: 3

About

Panluminate is a New Haven, Connecticut spatial biology company founded at Yale developing next-generation biological imaging technologies. Its core platform, pan-Expansion Microscopy (pan-ExM), enables nanoscale 3D cellular imaging at ~20x linear expansion, rivaling electron microscopy in resolution while leveraging standard fluorescence microscopes. The company also develops FLASH-PAINT multiplexed protein imaging and AI-driven image analysis for drug discovery, neuroscience, and oncology research.

Summary

PANLUMINATE INC is a Biotech company based in New Haven, United States, founded in 2022. It has raised $3.6M in total across 3 rounds, most recently a $1.4M Grant round in Jan 2025. Investors include National Institutes of Health.